JSP
Jackson Square Partners’s Pacific Biosciences PACB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $686K | Sell |
553,103
-2,767,258
| -83% | -$3.43M | 0.25% | 54 |
|
|
2025
Q1 | $3.92M | Sell |
3,320,361
-1,788,905
| -35% | -$2.11M | 0.53% | 48 |
|
|
2024
Q4 | $9.35M | Sell |
5,109,266
-1,186,850
| -19% | -$2.17M | 0.97% | 36 |
|
|
2024
Q3 | $10.7M | Sell |
6,296,116
-2,587,327
| -29% | -$4.4M | 0.92% | 35 |
|
|
2024
Q2 | $12.2M | Buy |
8,883,443
+1,699,130
| +24% | +$2.33M | 0.74% | 36 |
|
|
2024
Q1 | $26.9M | Sell |
7,184,313
-2,520,453
| -26% | -$9.45M | 1.12% | 34 |
|
|
2023
Q4 | $95.2M | Buy |
9,704,766
+2,770,901
| +40% | +$27.2M | 3.09% | 12 |
|
|
2023
Q3 | $57.9M | Sell |
6,933,865
-1,583,759
| -19% | -$13.2M | 1.93% | 23 |
|
|
2023
Q2 | $113M | Sell |
8,517,624
-3,580,337
| -30% | -$47.6M | 3.3% | 12 |
|
|
2023
Q1 | $140M | Sell |
12,097,961
-2,907,216
| -19% | -$33.7M | 3.79% | 9 |
|
|
2022
Q4 | $123M | Sell |
15,005,177
-5,252,922
| -26% | -$43M | 3.27% | 13 |
|
|
2022
Q3 | $118M | Sell |
20,258,099
-2,503,943
| -11% | -$14.5M | 3.08% | 11 |
|
|
2022
Q2 | $101M | Buy |
22,762,042
+219,453
| +1% | +$970K | 2.35% | 20 |
|
|
2022
Q1 | $205M | Buy |
22,542,589
+8,039,420
| +55% | +$73.2M | 2.04% | 13 |
|
|
2021
Q4 | $297M | Sell |
14,503,169
-33,502
| -0.2% | -$685K | 2.49% | 10 |
|
|
2021
Q3 | $371M | Sell |
14,536,671
-299,823
| -2% | -$7.66M | 2.35% | 11 |
|
|
2021
Q2 | $519M | Buy |
14,836,494
+1,924,799
| +15% | +$67.3M | 2.96% | 3 |
|
|
2021
Q1 | $430M | Sell |
12,911,695
-562,743
| -4% | -$18.7M | 2.44% | 8 |
|
|
2020
Q4 | $350M | Buy |
+13,474,438
| New | +$350M | 1.39% | 30 |
|